+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Valve Devices Market - Global Forecast 2026-2032- Product Image
Heart Valve Devices Market - Global Forecast 2026-2032- Product Image
Sale

Heart Valve Devices Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904527
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Heart Valve Devices Market is projected to reach USD 14.82 Billion in 2026. It is expected to continue growing at a CAGR of 10.39%, reaching USD 26.89 Billion by 2032.

Heart valve devices are central to the treatment of aortic, mitral, tricuspid, and pulmonary valve disease, spanning mechanical valves, bioprosthetic valves, annuloplasty systems, transcatheter aortic valve replacement (TAVR) platforms, transcatheter mitral repair and replacement technologies, and emerging tricuspid solutions.

Demand is supported by well-documented demographic and clinical drivers: population aging, the high prevalence of calcific aortic stenosis in older adults, persistent rheumatic heart disease burden in many low- and middle-income countries, and growing use of minimally invasive structural heart procedures. Hospitals, cardiac centers, and ambulatory cardiovascular programs are prioritizing heart valve devices that improve survival, reduce recovery time, and support durable outcomes under increasingly value-based reimbursement models.

Transformative Shifts in the Heart Valve Devices Landscape

The heart valve devices landscape is shifting from open surgical valve replacement toward catheter-based and hybrid structural heart interventions. TAVR has moved from inoperable and high-risk patients into broader risk categories in major markets, supported by randomized clinical evidence and guideline adoption. This has accelerated investment in delivery systems, imaging compatibility, valve durability, and treatment planning workflows.

Another transformative shift is the expansion beyond aortic valve disease. Mitral and tricuspid valve therapies are gaining clinical and commercial attention because these conditions are common in older and heart failure populations, yet historically undertreated. Device development is increasingly focused on precision delivery, reduced paravalvular leak, lower pacemaker rates, retrievability, and long-term hemodynamic performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the full heart valve device lifecycle, from diagnosis and patient selection to procedural planning and post-market surveillance. AI-enabled echocardiography, CT segmentation, and automated measurement tools can support more consistent assessment of annular dimensions, calcification, left ventricular function, and procedural risk.

The cumulative impact is operational as well as clinical. AI can improve cath lab scheduling, inventory planning, and real-world evidence generation by analyzing registry data, imaging archives, and electronic health records. However, adoption depends on validated algorithms, transparent regulatory pathways, cybersecurity controls, and clinician oversight to ensure that AI augments, rather than replaces, expert structural heart decision-making.

Key Regional Insights

Asia-Pacific is a high-opportunity region as China, India, Japan, South Korea, and Australia expand structural heart programs, while large elderly populations and improving access to tertiary cardiac care increase demand for both surgical and transcatheter heart valve devices. Japan and Australia benefit from mature reimbursement systems and advanced hospital infrastructure, while China and India combine large patient pools with rising domestic manufacturing capabilities, improving diagnostic access, and public-private investment in cardiac care.

North America remains a leading innovation and adoption hub due to high structural heart procedure volumes, sophisticated imaging infrastructure, strong clinical trial activity, and established reimbursement for approved TAVR and selected transcatheter valve procedures. Europe shows broad clinical expertise and guideline-driven adoption, with the European Union emphasizing medical device regulation, evidence generation, unique device identification, and post-market performance monitoring for cardiovascular implants.

Latin America, the Middle East, and Africa present mixed but important adoption conditions. Brazil and Mexico anchor Latin American demand through large urban cardiology networks and public-private treatment pathways, while GCC countries in the Middle East invest in specialist cardiac centers, advanced imaging, and medical tourism. In Africa, rheumatic heart disease continues to drive valve disease burden, particularly among younger populations, but access is constrained by specialist availability, affordability, uneven surgical capacity, and limited structural heart infrastructure.

Key Group Insights

Within ASEAN, expanding urban hospital networks and rising cardiovascular disease awareness are supporting gradual uptake of heart valve devices, especially in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. Access remains uneven across the region, making reimbursement design, physician training, referral pathways, and regional centers of excellence critical for wider adoption of surgical valves, TAVR, and emerging mitral and tricuspid interventions.

The GCC is characterized by high healthcare investment, growing structural heart capabilities, and demand for premium minimally invasive cardiovascular technologies. The European Union is shaped by rigorous clinical evidence expectations under the Medical Device Regulation, while BRICS countries combine large unmet need with cost-sensitive procurement, expanding tertiary hospital capacity, and growing domestic production capacity for cardiovascular devices.

G7 markets lead in innovation, clinical trial density, advanced imaging, registry participation, and early adoption of next-generation transcatheter valve devices. NATO countries overlap significantly with high-income cardiovascular markets, where procurement resilience, supply chain security, cybersecurity readiness, and clinical standardization are increasingly important to hospital systems, payers, and device manufacturers.

Key Country Insights

The United States is the largest commercial and clinical innovation market for heart valve devices, supported by FDA-authorized technologies, large registry infrastructure, high TAVR penetration, and extensive structural heart programs. Canada follows evidence-based adoption through provincial health systems, while Mexico is expanding access through private hospitals and major urban cardiac centers. Brazil is Latin America's key market, with demand shaped by public-private care pathways, advanced cardiology hubs, and the continued need to address both degenerative and rheumatic valve disease.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong procedure capabilities and established cardiothoracic and interventional cardiology expertise, with Germany historically recognized for high structural heart procedure volumes. Russia has demand from aging populations and cardiovascular disease burden, although access to advanced technologies can be affected by procurement complexity, reimbursement variation, and geopolitical constraints.

China and India represent large long-term opportunities due to population scale, aging demographics, rising diagnosis of valvular heart disease, and expanding cardiac infrastructure. Japan and South Korea are advanced technology markets with strong physician expertise, high-quality hospital systems, and structured adoption of minimally invasive valve procedures, while Australia combines high clinical standards, reimbursement discipline, registry-based evaluation, and systematic adoption of approved heart valve technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, including long-term durability, quality-of-life outcomes, reduced rehospitalization, stroke and pacemaker outcomes, and device performance in anatomically complex patients. Evidence strategies should include randomized trials where feasible, real-world registries, health-economic analyses, and post-market surveillance aligned with regulatory expectations for implantable cardiovascular devices.

Manufacturers should also invest in physician education, imaging-based planning tools, proctoring programs, and center-of-excellence partnerships to improve outcomes and accelerate appropriate adoption. Commercial strategies should balance premium innovation in mature markets with affordability, local partnerships, training infrastructure, and service support in emerging markets where diagnosis and treatment access gaps remain substantial.

Research Methodology

This executive summary is based on structured secondary research, including peer-reviewed cardiology literature, major society guidelines, public regulatory documents, clinical trial registries, hospital adoption trends, and epidemiological sources covering valvular heart disease and cardiovascular care.

The analysis applies cross-validation across clinical, regulatory, demographic, and commercial indicators. Regional, group, and country insights were assessed through healthcare infrastructure, reimbursement maturity, disease burden, procedure adoption, availability of specialist structural heart programs, regulatory readiness, and access to advanced cardiac imaging.

Conclusion

Heart valve devices are positioned for continued advancement as aging populations, underdiagnosed valve disease, and clinical preference for minimally invasive intervention reshape cardiovascular care. TAVR remains the benchmark for transformation, while mitral and tricuspid innovation is opening the next phase of structural heart development.

Organizations that combine robust clinical evidence, AI-enabled workflow support, physician training, resilient supply chains, and market-specific access strategies will be best positioned to improve adoption while strengthening patient outcomes across mature and emerging healthcare systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Heart Valve Devices Market, by Valve Position
7.1. Introduction
7.2. Aortic Valve
7.3. Mitral Valve
7.4. Pulmonary Valve
7.5. Tricuspid Valve
8. Heart Valve Devices Market, by Product Type
8.1. Introduction
8.2. Mechanical Heart Valves
8.2.1. Bileaflet
8.2.2. Tilting Disc
8.2.3. Caged Ball
8.3. Biological Heart Valves
8.3.1. Xenograft
8.3.2. Homograft
9. Heart Valve Devices Market, by Procedure Type
9.1. Introduction
9.2. Transcatheter Valve Interventions
9.3. Open-Heart Surgery
9.4. Minimally Invasive Surgery
10. Heart Valve Devices Market, by Age Group
10.1. Introduction
10.2. Adult
10.3. Pediatric
10.4. Geriatric
11. Heart Valve Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Cardiology Clinics
11.5. Research & Academic Centers
12. Heart Valve Devices Market, by Distribution Channel
12.1. Introduction
12.2. Online
12.3. Offline
13. Heart Valve Devices Market, by Region
13.1. Europe
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Middle East
13.6. Africa
14. Heart Valve Devices Market, by Group
14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC
15. Heart Valve Devices Market, by Country
15.1. United States
15.2. Germany
15.3. China
15.4. Japan
15.5. United Kingdom
15.6. India
15.7. France
15.8. South Korea
15.9. Canada
15.10. Australia
15.11. Italy
15.12. Spain
15.13. Russia
15.14. Brazil
15.15. Mexico
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Edwards Lifesciences Corporation
17.2. Medtronic plc
17.3. Abbott Laboratories
17.4. Boston Scientific Corporation
17.5. Corcym S.r.l.
17.6. Artivion, Inc
17.7. Peijia Medical Limited
17.8. Meril Life Sciences Pvt. Ltd.
17.9. Venus Medtech (Hangzhou) Inc.
17.10. Lepu (Beijing) Medical Devices Co., Ltd.
17.11. Biosensors International Group, Ltd.
17.12. MicroPort Scientific Corporation
17.13. JenaValve Technology, Inc.
17.14. 4C Medical Technologies, Inc.
17.15. Anteris Technologies Global Corp.
17.16. Braile Biomédica
17.17. Colibri Heart Valve LLC
17.18. Foldax, Inc.
17.19. HighLife Medical
17.20. Sahajanand Medical Technologies Limited
17.21. TTK Healthcare Limited
17.22. W. L. Gore & Associates, Inc.
17.23. Xeltis B.V.
List of Figures
FIGURE 1. GLOBAL HEART VALVE DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HEART VALVE DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HEART VALVE DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HEART VALVE DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HEART VALVE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL AORTIC VALVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL AORTIC VALVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL AORTIC VALVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MITRAL VALVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MITRAL VALVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MITRAL VALVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PULMONARY VALVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PULMONARY VALVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL TRICUSPID VALVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL TRICUSPID VALVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL TRICUSPID VALVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL BILEAFLET MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL BILEAFLET MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BILEAFLET MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TILTING DISC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TILTING DISC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TILTING DISC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CAGED BALL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CAGED BALL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CAGED BALL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICAL HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICAL HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL XENOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL XENOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL XENOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL HOMOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL HOMOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL HOMOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL TRANSCATHETER VALVE INTERVENTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSCATHETER VALVE INTERVENTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSCATHETER VALVE INTERVENTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SPECIALTY CARDIOLOGY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SPECIALTY CARDIOLOGY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SPECIALTY CARDIOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL RESEARCH & ACADEMIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RESEARCH & ACADEMIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL RESEARCH & ACADEMIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. EUROPE HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. EUROPE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 81. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 82. EUROPE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 83. EUROPE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 84. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 85. EUROPE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 86. EUROPE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 87. EUROPE HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 124. AFRICA HEART VALVE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 126. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 128. AFRICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 129. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 131. AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. AFRICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. NATO HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. NATO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 136. NATO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. NATO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 138. NATO HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 139. NATO HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 140. NATO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 141. NATO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. NATO HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 143. G7 HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. G7 HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 145. G7 HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. G7 HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 147. G7 HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 148. G7 HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 149. G7 HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 150. G7 HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. G7 HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 161. BRICS HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. BRICS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 163. BRICS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 164. BRICS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 165. BRICS HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 166. BRICS HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 167. BRICS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 168. BRICS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. BRICS HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 170. ASEAN HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. ASEAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 172. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 173. ASEAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 174. ASEAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 175. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 176. ASEAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 177. ASEAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. ASEAN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 179. GCC HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GCC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 181. GCC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 182. GCC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 183. GCC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 184. GCC HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 185. GCC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 186. GCC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. GCC HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 198. GERMANY HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 199. GERMANY HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 200. GERMANY HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. GERMANY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 202. GERMANY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 203. GERMANY HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 204. GERMANY HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 205. GERMANY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. GERMANY HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 207. CHINA HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. CHINA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 209. CHINA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. CHINA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 211. CHINA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 212. CHINA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 213. CHINA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 214. CHINA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. CHINA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. JAPAN HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. JAPAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 218. JAPAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. JAPAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 220. JAPAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 221. JAPAN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 222. JAPAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 223. JAPAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. JAPAN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 234. INDIA HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. INDIA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 236. INDIA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. INDIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 238. INDIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 239. INDIA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 240. INDIA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 241. INDIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. INDIA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 243. FRANCE HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. FRANCE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 245. FRANCE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 246. FRANCE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 247. FRANCE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 248. FRANCE HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 249. FRANCE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 250. FRANCE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. FRANCE HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 254. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 255. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 256. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 257. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 258. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 259. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. CANADA HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 262. CANADA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 263. CANADA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 264. CANADA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 265. CANADA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 266. CANADA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 267. CANADA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 268. CANADA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. CANADA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 272. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 274. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 275. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 276. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 277. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 279. ITALY HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. ITALY HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 281. ITALY HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. ITALY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 283. ITALY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 284. ITALY HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 285. ITALY HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 286. ITALY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. ITALY HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 288. SPAIN HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 289. SPAIN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 290. SPAIN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. SPAIN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 292. SPAIN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 293. SPAIN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 294. SPAIN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 295. SPAIN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. SPAIN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 312. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 315. MEXICO HEART VALVE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. MEXICO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2017-2032 (USD MILLION)
TABLE 317. MEXICO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 318. MEXICO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 319. MEXICO HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2017-2032 (USD MILLION)
TABLE 320. MEXICO HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 321. MEXICO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 322. MEXICO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. MEXICO HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 324. GLOBAL HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 325. GLOBAL HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Corcym S.r.l.
  • Artivion, Inc
  • Peijia Medical Limited
  • Meril Life Sciences Pvt. Ltd.
  • Venus Medtech (Hangzhou) Inc.
  • Lepu (Beijing) Medical Devices Co., Ltd.
  • Biosensors International Group, Ltd.
  • MicroPort Scientific Corporation
  • JenaValve Technology, Inc.
  • 4C Medical Technologies, Inc.
  • Anteris Technologies Global Corp.
  • Braile Biomédica
  • Colibri Heart Valve LLC
  • Foldax, Inc.
  • HighLife Medical
  • Sahajanand Medical Technologies Limited
  • TTK Healthcare Limited
  • W. L. Gore & Associates, Inc.
  • Xeltis B.V.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.82 Billion
Forecasted Market Value ( USD ) by 2032 $ 26.89 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Heart Valve Repair & Replacement Devices Market - Global Forecast 2026-2032 - Product Image

Heart Valve Repair & Replacement Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Prosthetic Heart Valves Market - Global Forecast 2026-2032 - Product Image

Prosthetic Heart Valves Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Transcatheter Heart Valves - Global Strategic Business Report - Product Image

Transcatheter Heart Valves - Global Strategic Business Report

  • Report
  • 247 Pages
  • Global
From
Heart Valve Repair and Replacement Devices - Global Strategic Business Report - Product Image

Heart Valve Repair and Replacement Devices - Global Strategic Business Report

  • Report
  • 446 Pages
  • Global
From
Tissue Heart Valves - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Tissue Heart Valves - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.